Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

被引：0
|
作者：
Teuber, G
Kallinowski, B
Niederau, C
Klinker, H
Galle, PR
Zankel, M
Zeuzem, S
机构：
[1] Med Klin 2, Frankfurt, Germany
[2] Innere Med 4, Heidelberg, Germany
[3] St Josef Hosp, Oberhausen, Germany
[4] Luitpold Krankenhaus, Wurzburg, Germany
[5] Med Klin 1, Mainz, Germany
[6] Essex Pharma, Munich, Germany
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
10.1016/S0168-8278(03)80873-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
607
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [21] Treatment with amantadine plus ribavirin plus interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy.
    Ferenci, P
    Stauber, R
    Hackl, F
    Schuetze, K
    Bauer, B
    Datz, C
    GASTROENTEROLOGY, 2000, 118 (04) : A1437 - A1437
  • [22] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [23] Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients
    Taliani, G
    Gemignani, G
    Ferrari, C
    Aceti, A
    Bartolozzi, D
    Blanc, PL
    Capanni, M
    Esperti, F
    Forte, P
    Guadagnino, V
    Mari, T
    Marino, N
    Milani, S
    Pasquazzi, C
    Rosina, F
    Tacconi, D
    Toti, M
    Zignego, AL
    Messerini, L
    Stroffolini, T
    GASTROENTEROLOGY, 2006, 130 (04) : 1098 - 1106
  • [24] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Kainuma, Mosaburo
    Furusyo, Norihiro
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Nomura, Hideyuki
    Tanabe, Yuichi
    Satoh, Takeaki
    Maruyama, Toshihiro
    Nakamuta, Makoto
    Kotoh, Kazuhiro
    Azuma, Koichi
    Shimono, Junya
    Shimoda, Shinji
    Hayashi, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (35) : 4400 - 4409
  • [25] Pegylated interferon alpha 2b (PEG IFN) plus ribavirin (R) for treatment of chronic hepatitis C: Optimization of ribavirin dose
    Manns, M
    Mc Hutchison, JG
    Gordorn, S
    Rustgi, V
    Lee, MV
    Ling, ML
    Cohard, M
    Albrecht, JK
    JOURNAL OF HEPATOLOGY, 2001, 34 : 236 - 236
  • [26] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Goncales, Fernando L., Jr.
    Moma, Camila A.
    Vigani, Aline G.
    Angerami, Adriana F. C. F.
    Goncales, Eduardo S. L.
    Tozzo, Raquel
    Pavan, Maria H. P.
    Goncales, Neiva S. L.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [27] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Mosaburo Kainuma
    Norihiro Furusyo
    Eiji Kajiwara
    Kazuhiro Takahashi
    Hideyuki Nomura
    Yuichi Tanabe
    Takeaki Satoh
    Toshihiro Maruyama
    Makoto Nakamuta
    Kazuhiro Kotoh
    Koichi Azuma
    Junya Shimono
    Shinji Shimoda
    Jun Hayashi
    World Journal of Gastroenterology, 2010, 16 (35) : 4400 - 4409
  • [28] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Gonçales
    Camila A Moma
    Aline G Vigani
    Adriana FCF Angerami
    Eduardo SL Gonçales
    Raquel Tozzo
    Maria HP Pavan
    Neiva SL Gonçales
    BMC Infectious Diseases, 10
  • [29] Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
    Ferenci, Peter
    Scherzer, Thomas-Matthias
    Kerschner, Heidrun
    Rutter, Karoline
    Beinhardt, Sandra
    Hofer, Harald
    Schoeniger-Hekele, Maximilian
    Holzmann, Heidemarie
    Steindl-Munda, Petra
    GASTROENTEROLOGY, 2008, 135 (05) : 1561 - 1567
  • [30] Double-blind, placebo-controlled trial of interferon alpha-2b plus ribavirin versus interferon alpha-2b for retreatment of patients with chronic hepatitis C who failed previous treatment with interferon alpha.
    Sarabanchong, V
    Reinus, J
    Clain, DJ
    Aytaman, A
    Levendoglu, H
    Bloom, AA
    De La Riva, E
    Spinnell, M
    Puppo, MD
    McMahon, DJ
    Garcia-Carrasquillo, RJ
    Magun, AM
    Worman, HJ
    HEPATOLOGY, 1998, 28 (04) : 703A - 703A
12345